USA: Proposal to recall Avandia medicine for diabetes

For reasons of low therapeutic effect and risk of heart disease, on 30.7, leading scientist of the US Federal Food and Drug Administration (FDA), Dr. David Graham, officially recommended The FDA issued a recall to recall Avandia drugs currently in common use in the United States to treat diabetes.

According to a distribution report before a day-long conference in Washington's capital among FDA officials and experts to assess the effectiveness of the drug, Dr. Graham confirmed that Avandia is not only It's not immediately effective that helps diabetics control their blood sugar levels, but also lead to cardiovascular disease.

Avandia diabetes medicine.
(Photo: digiweb.ihned.cz)

Dr. Graham suggested writing a strict warning on the packaging or removing Avandia completely from the market. Dr. Graham's conclusions are also consistent with the results of previous studies on Avandia drugs produced by GlaxoSmithKline PLC, which also addresses the potential risks of heart disease for patients. Use the above drug, even if the representative of Glaxo company has not accepted this conclusion.

The July 30 conference was convened by the FDA after the May issue of "The New England Journal of Medicine" reported that 43 out of 42 patients using Avandia had a higher risk of heart disease. than people who use other diabetes medications or those who do not.

Currently in the United States, about 1 million people with type 2 diabetes are taking Avandia drugs to control blood sugar.

PV